Navigation Links
Asmacure Ltee Issued Patent to Govern Composition-of-Matter for its Nicotinic Receptor Technology in the U.S.
Date:10/25/2011

QUEBEC CITY, Oct. 25, 2011 /PRNewswire/ -- Asmacure Ltee, a clinical-stage biopharmaceutical company focused on the development of nicotinic receptor agonists for the treatment of asthma and other inflammatory diseases, announced today that it has been issued U.S. patent No. 8,039,459 from the United States Patent & Trademark Office (USPTO) entitled "Nicotinic Receptor Agonists for the Treatment of Inflammatory Diseases."  The first patent of this series in the USPTO comprises compounds and pharmaceutical composition claims.

"The issuance of these patents in the U.S. and Japan are important developments for the strong global intellectual property estate for our lead compound, ASM-024," said Mr. Martin Driscoll, CEO of Asmacure. "This important expansion of the patent protection for ASM-024 is another milestone in the development of our proprietary new mechanism for the treatment of asthma and other respiratory inflammatory diseases."

The nicotinic receptor agonist compounds developed for the treatment of pulmonary inflammatory diseases were discovered at the Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Quebec, a research center affiliated with Universite Laval. Asmacure has an exclusive license from Universite Laval to develop and commercialize any product derived from this technology.

On July 15, 2011, the Japan Patent Office issued the corresponding Japanese patent No. 4783787.  The claims within the patent are directed to compounds as well as pharmaceutical compositions for treating or preventing pulmonary inflammatory diseases.

About Asmacure

Asmacure Ltee is a clinical-stage biopharmaceutical company focused on the development of nicotinic receptor agonists for the treatment of asthma and other inflammatory diseases. The company's lead compound, ASM-024, is a novel molecular entity currently in clinical development for the treatment of asthma. ASM-024 utilizes Asmacure's proprietary technology comprised of nicotinic acetylcholine receptor agonists and is the first nicotinic receptor agonist in the clinic for this indication.  Phase II proof-of-concept studies are ongoing to assess the anti-inflammatory, bronchodilating and bronchoprotective properties of ASM-024 administered by inhalation.  

Asmacure is a privately held company located in Quebec City, Canada. The major investors in Asmacure include Domain Associates, Fonds Bio-Innovation and Innovatech Quebec. For more information visit www.asmacure.com

Media Contacts:
Tiberend Strategic Advisors, Inc.
(212) 827-0020
Andrew Mielach, amielach@tiberend.com
or
Claire Sojda, csojda@tiberend.com


'/>"/>
SOURCE Asmacure Ltee
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Asmacure Ltee to Present at the 2011 BIO Business Forum During the Annual BIO International Convention
2. Vantage Health Announces That All of Its Required Tanzanian Registrations, Permits and Licenses Have Been Formally Issued, Simultaneous With Official Notification That Its Application for Phase One Evaluation of Its HIV Screening Test Kits Has Been
3. Curemark Issued Patent for the Diagnosis of Parkinsons Disease
4. Urgent Call Is Issued for More Local Doctors and Nurses for Mondays Free Health Clinic
5. U.S. Patent for Leatt Neck Brace System Issued
6. China Medical Technologies Announces the First Inclusion of FISH Tests for Diagnosis of Certain Hematological Malignancies in the Clinical Guidelines Issued by the MOH
7. PRA Experts Pulmonary Function Textbook Reissued
8. Voluntary Worldwide Field Correction Issued for the S98/98XT, CS100/CS100i and CS300 Intra-Aortic Balloon Pumps
9. Applied Medical Sues Covidien, Asserting Recently Issued Universal Seal Trocar Patent
10. Landmark Patents Issued for ViewRay Technology
11. Two New U.S. Patents Issued to Dyadic International
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... Pharmaceutical giant Johnson & Johnson has been ... says its talc-based powder products caused ovarian cancer. The ... million in compensatory damages and $50 million in punitive ... , This is the second in a ... same court awarded $72 million to the family of ...
(Date:5/3/2016)... 3, 2016  Specialty Silicone Fabricators is offering ... how a cleanroom works. The free visual aid ... and technology. Chris Mazelin ... company, SSF enthusiastically supports the Science, Technology, Engineering ... the next generation of innovators. We want to ...
(Date:5/3/2016)... 3, 2016  Forté Elements, LLC (Forté) is excited to announce the launch of ... the nutritional needs of recovery for a variety of clinical conditions. Founded in 2013, ... - http://photos.prnewswire.com/prnh/20160502/362548 Logo -  http://photos.prnewswire.com/prnh/20160502/362547LOGO ... ... ...
Breaking Medicine Technology:
(Date:5/4/2016)... ... May 04, 2016 , ... A new collaboration will ... The Duke Clinical Research Institute (DCRI) and analytics leader SAS will provide researchers worldwide ... collected by the Duke University Health System. , The DCRI and SAS share ...
(Date:5/4/2016)... ... 04, 2016 , ... May kicked off with Melanoma Monday , a ... Dr. Ellen Turner is encouraging her patients, as well as residents all around Dallas, ... and health now and in the future. , The dermatology-specific awareness month ends with ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... nutrients that supports cellular and metabolic health. This synergistic combination of omega-3 fatty ... curcumin, along with 150 mg of reduced glutathione and 200 mg of N-Acetylcysteine ...
(Date:5/4/2016)... Plainsboro, NJ (PRWEB) , ... May 04, 2016 ... ... for pharmacists and the pharmacy industry, today announced that it was chosen as ... Purchasing Alliance (APPA) Industry Awards . The awards acknowledge the hard work and ...
(Date:5/4/2016)... ... 04, 2016 , ... AudioEducator is the country's top training ... AudioEducator has lined up some informative training session for the medical coding and ... know-how and practical, easy-to-apply advice. , On Thursday, May 19, AudioEducator will host ...
Breaking Medicine News(10 mins):